Answers are grounded in this paper and cite their sources.
Retrospective study reports diverse multisystem manifestations in 76 COVID-19 patients, highlighting the prevalence of both respiratory symptoms and vascular complications.
Background: Coronavirus disease 2019 (COVID-19) emerged in December 2019 in Wuhan, the capital of Hubei province, China. COVID-19 is an acute respiratory disease caused by a newly emerged zoonotic coronavirus. The virus is now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease it causes is called coronavirus disease 2019 (COVID-19). In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic. Aim of the work: Clinical description of COVID-19 patients presented to El-Minia University Hospital Screening Triage. Identification of different varieties of COVID-19 clinical manifestations and complications. Patients and Methods: A retrospective study on the clinical manifestation and complications of 76 patients of COVID-19. Results: Average age 50 years old 43 male and 33 female. 29% with previous history of smoking, 26% with hypertension, 15% diabetic patient and 9% chronic kidney disease. The most common presentation is fever 80%, dry cough 81.6% and shortness of breath 75%, productive cough 9%, anosmia 18.4%, myalgia and bone aches in 60.5%, easy fatigability 61.8% and persistent headache in 34%. GIT manifestations including diarrhea 22% and vomiting 14.5%. Another 3 cases diagnosed as mesenteric vascular occlusion and 2 cases presented with eye involvement. The acute kidney injury (AKI) occurred in 5.3% of the patients. Conclusion: SARS COV-2 can present with different clinical manifestation affecting multiple body systems.
No takes yet. Share an insight, caveat, or question.
Refat et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: